Aprotinin application has no negative effect on osseous implant integration: A biomechanical and histomorphometric investigation in a rat model

Archives of Orthopaedic and Trauma Surgery

Volumn 129, Issue 1, 2009, Pages 51-56

  Faensen, B ^a   Hain, C ^a   Hohne J ^a   Schwabe, P ^a   Haas, N ^a   Schmidmaier, G ^a   Wildemann, Britt ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allogenic blood transfusion (ABT); Aprotinin; Osseous implant ingrowth

Indexed keywords

APROTININ; SODIUM CHLORIDE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; BONE GROWTH; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FEMUR; HISTOLOGY; INTRAMEDULLARY NAILING; METAL IMPLANTATION; MORPHOMETRICS; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SHEAR STRESS;

ANIMALS; APROTININ; BIOMECHANICS; BLOOD LOSS, SURGICAL; FEMALE; FEMUR; HEMOSTATICS; ORTHOPEDIC PROCEDURES; OSSEOINTEGRATION; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 56249138645     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-008-0582-1     Document Type: Article

References (29)

1. Beierlein W, Scheule AM, Dietrich W, Ziemer G (2005) Forty years of clinical aprotinin use: A review of 124 hypersensitivity reactions. Ann Thorac Surg 79(2):741-748
2. Bethge JF, Babayan R, Borm HP, von Fehrentheil R, ten Hoff H, Hose H, Mangels P, Piening H, Reimers C, Wider U (1979) Experimental acceleration of fracture repair by biochemical media. Res Exp Med (Berl) 175(3):197-222
3. Brown JR, Birkmeyer NJ, O'Connor GT (2007) Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115(22):2801-2813
4. Clasen C, Jochum M, Mueller-Ester W (1987) Feasibility study of very high dose aprotinin in polytrauma patients. In: Schlag G, Red1 H (eds) First Vienna Shock Forum. Pathophysiological role of mediators and mediator inhibitors in shock. Liss, New York, pp 175-183
5. Engles L (2005) Review and application of serine protease inhibition in coronary artery bypass graft surgery. Am J Health Syst Pharm 62:S9-14
6. Fiebig E (1998) Safety of the blood supply. Clin Orthop 357:6-18
7. Frost A, Jonsson KB, Ridefelt P, Nilsson O, Ljunghall S, Ljungren O (1999) Thrombin, but not bradykinin, stimulates proliferation in isolated human osteoblasts, via a mechanism not dependent on endogenous prostaglandin formation. Acta Orthop Scand 70(5):497-503
8. Hunter D (2006) First gather the data. N Engl J Med 354(4):329-331
9. Innerhofer P, Walleczek C, Luz G, Hobisch-Hagen P, Benzer A, Stockl B, Hessenberger G, Nussbaumer W, Schobersberger W (1999) Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 39(6):625-632
10. Kokoszka A, Kuflik P, Bitan F, Casden A, Neuwirth M (2005) Evidence-based review of the role of aprotinin in blood conservation during orthopaedic surgery. J Bone Joint Surg Am 87(5):1129-1136
11. Krishnan LK, Vijayan Al A, Uma Shankar PR, Mohanty M (2003) Fibrinolysis inhibitors adversely affect remodeling of tissues sealed with fibrin glue. Biomaterials 24(2):321-327
12. Lerner UH (1994) Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute-phase reactants. Oral Surg Oral Med Oral Pathol 78(4):481-493
13. Lerner UH, Gustafson GT (1988) Blood coagulation and bone metabolism: some characteristics of the bone resorptive effect of thrombin in mouse calvarial bones in vitro. Biochim Biophys Acta 964(3):309-318
14. Levy JH, Despotis GJ, Spitznagel E (2006) Should aprotinin continue to be used during cardiac surgery? Nat Clin Pract Cardiovasc Med 3(7):360-361
15. Levy JH, Sypniewski E (2004) Aprotinin: A pharmacologic overview. Orthopedics 27(6 Suppl):s653-658 (review)
16. Lien M, Milbrandt EB (2006) A disheartening story: Aprotinin in cardiac surgery. Crit Care 10(6):317
17. Mangano DT, Tudor IC, Dietzel C (2006) Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation: The risk associated with aprotinin in cardiac surgery. N Engl J Med 354(4):353-365
18. Murkin JM, Haig GM, Beer KJ, Cicutti N, McCutchen J, Comunale ME, Hall R, Ruzicka BB (2000) Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg Am 82:675-684
19. Murphy P, Heal JM, Blumberg N (1991) Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 31(3):212-217
20. Pagel CN, Sivagurunathan S, Loh LH, Tudor EM, Pike RN, Mackie EJ (2006) Functional responses of bone cells to thrombin. Biol Chem 387(8):1037-1041
21. Pagel CN, de Niese MR, Abraham LA, Chinni C, Song SJ, Pike RN, Mackie EJ (2003) Inhibition of osteoblast apoptosis by thrombin. Bone 33(4):733-43; Erratum in Bone 2004 July; 35(1):343
22. Pintigny D, Dachary-Pregent J (1992) Aprotinin can inhibit the proteolytic activity of thrombin. A fluorescence and an enzymatic study. Eur J Biochem 207(1):89-95
23. Ray M, Hatcher S, Whitehouse SL, Crawford S, Crawford R (2005) Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty - a prospective randomized double-blind placebo-controlled study. J Thromb Haemost 3:1421-1427
24. Royston D (1992) High-dose aprotinin therapy: A review of the first five years' experience. J Cardiothorac Vasc Anesth 6(1):76-100
25. Royston D, Taylor KM, Bidstrup BP, Sapsford RN (1987) Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2:1289-1291
26. Schmidmaier G, Wildemann B, Schwabe P, Stange R, Hoffmann J, Sudkamp NP, Haas NP, Raschke M (2002) A new electrochemically graded hydroxyapatite coating for osteosynthetic implants promotes implant osteointegration in a rat model. J Biomed Mater Res 63:168-172
27. Shiga T, Wajima Z, Inoue T, Sakamoto A (2005) Aprotinin in major orthopedic surgery: A systematic review of randomized controlled trials. Anesth Analg 101(6):1602-1607
28. Smith PK, Muhlbaier LH (1996) Aprotinin: Safe and effective only with the full-dose regimen. Ann Thorac Surg 62:1575-1577
29. Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, Brucek P, Maly M (2005) Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg 28:563-568